天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

sangon Company Information
Company Name:   
Tel:    -
Email:    sangon@qq.com
Nationality:    CHINA
WebSite:    www.sangon.com
Product List:    47239
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318
Product List
5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate, 10 mM in DMS 239463-85-5
Taltirelin acetate, 10 mM in DMSO 1549593-23-8
(3Z)-1-methyl-3-[2-(4-methylphenyl)-2-oxo-ethylidene]piperazin-2-one, 10 mM in DMSO 178408-16-7
NVP-TAE 684, 10 mM in DMSO 761439-42-3
LY3405105 2326428-25-3
5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE, 10 mM in DMSO 17899-49-9
AG-270, 10 mM in DMSO 2201056-66-6
TAK-615, 10 mM in DMSO 1664335-55-0
TAS0728, 10 mM in DMSO 2088323-16-2
TAK-020, 10 mM in DMSO 1627603-21-7
TAK-779, 10 mM in DMSO 229005-80-5
TAK-901 934541-31-8
Tanimilast 1239278-59-1
TAK-593, 10 mM in DMSO 1005780-62-0
TAK-243, 10 mM in DMSO 1450833-55-2
TAK-653 1358751-06-0
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)pyrazine-2-carboxamide, 10 mM in DMSO 312508-42-2
TAK-659 hydrochloride 1952251-28-3
N,N,O-Tridesmethylvenlafaxine, 10 mM in DMSO 149289-29-2
3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile, 10 mM in DMSO 2759137-87-4
(S)-2-((R)-3-(4-chlorophenyl)-N’-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide, 1404117-65-2
MAT2A inhibitor 4, 10 mM in DMSO 1391934-91-0
5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione 26166-92-7
2-(2,6-dioxopiperidin-3-yl)-4-((7-hydroxyheptyl)oxy)isoindoline-1,3-dione 2093536-10-6
Fasiglifam, 10 mM in DMSO 1000413-72-8
Taprenepag, 10 mM in DMSO 752187-80-7
NVP-TAE 226, 10 mM in DMSO 761437-28-9
TAK-632, 10 mM in DMSO 1228591-30-7
Targapremir-210 1049722-30-6
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate, 10 mM in DMSO 160969-03-9
TA-02, 10 mM in DMSO 1784751-19-4
Thalidomide-PEG4-Propargyl 2098799-77-8
Tanzisertib, 10 mM in DMSO 899805-25-5
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide, 10 mM in DMSO 2505001-62-5
Pomalidomide-PEG2-OH 2143097-10-1
Pomalidomide-PEG3-OH 2140807-36-7
2-(2,6-dioxopiperidin-3-yl)-4-((9-hydroxynonyl)oxy)isoindoline-1,3-dione 2619511-72-5
Cyclopenta[c][1]benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aR,4S,9bS)-rel-, 10 mM in DMSO 533883-77-1
T-900607, 10 mM in DMSO 261944-52-9
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine 1071135-06-2
Takinib, 10 mM in DMSO 1111556-37-6
Thalidomide-NH-C2-PEG3-OH 2140807-23-2
NSC 73150, 10 mM in DMSO 66680-03-3
Subasumstat, 10 mM in DMSO 1858276-04-6
Talnetant, 10 mM in DMSO 174636-32-9
GPR34 receptor antagonist 2, 10 mM in DMSO 907952-06-1
4-[(E)-{[4,6-Di(4-morpholinyl)-1,3,5-triazin-2-yl]hydrazono}methy l]-2,6-dimethoxyphenol, 10 mM in DMSO 321557-16-8
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide, 10 mM in DMSO 246238-55-1
TAK-285, 10 mM in DMSO 871026-44-7
(1S,4R)-N-Desmethyl Sertraline Hydrochloride, 10 mM in DMSO 675126-07-5
KCNQ2/3 activator-1, 10 mM in DMSO 1009344-33-5
TAK-715, 10 mM in DMSO 303162-79-0
Benzonitrile, 3,3''-[(2-oxo-1,3-cyclohexanediylidene)dimethylidyne]bis- (9CI), 10 mM in DMSO 63476-70-0
TAO Kinase inhibitor 1, 10 mM in DMSO 850467-66-2
Taprizosin 210538-44-6
TAK-071, 10 mM in DMSO 1820812-16-5
Takeda-6d, 10 mM in DMSO 1125632-93-0
TAM-IN-2 2135642-56-5
TAK-441 1186231-83-3
Talampanel, 10 mM in DMSO 161832-65-1
SCR130, 10 mM in DMSO 2377858-38-1
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline, 10 mM in DMSO 1352608-94-6
TAI-1, 10 mM in DMSO 1334921-03-7
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-, 10 mM in DMSO 80305-11-9
Taminadenant, 10 mM in DMSO 1337962-47-6
Fosravuconazole L-lysine ethanolate 914361-45-8
2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]-, 10 mM 1021917-65-6
5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, rel-, 10 mM in DMSO 1194954-52-3
GR103545, 10 mM in DMSO 126766-43-6
Taladegib 1258861-20-9
TAE-1 1414469-59-2
Takeda103A, 10 mM in DMSO 865609-72-9
C/EBPα inducer 1 2374285-52-4
TA-01, 10 mM in DMSO 1784751-18-3
GP130 receptor agonist-1, 10 mM in DMSO 339303-87-6
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole, 10 mM in DMSO 2863687-18-5
Tafetinib 1032265-57-8
(D-Trp12,Tyr34)-pTH (7-34) amide (bovine) acetate
1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID, 10 mM in DMSO 260555-42-8
Balipodect, 10 mM in DMSO 1238697-26-1
Targocil, 10 mM in DMSO 1200443-21-5
4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-, 10 mM in DMSO 939760-13-1
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate, 10 mM in DMSO 2738381-94-5
Tabernanthalog, 10 mM in DMSO 2483829-58-7
TAK-041, 10 mM in DMSO 1929519-13-0
Tarloxotinib bromide, 10 mM in DMSO 1636180-98-7
4-(6,7-dimethoxyquinolin-4-yl)oxyaniline, 10 mM in DMSO 190728-25-7
gamma-preprotachykinin amide (72-92) acetate
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid, 10 mM in DMSO 452105-33-8
Talabostat mesylate, 10 mM in DMSO 150080-09-4
Exo-1, 10 mM in DMSO 461681-88-9
TAK-733, 10 mM in DMSO 1035555-63-5
EAAT2 activator 1, 10 mM in DMSO 892415-28-0
Dazonone, 10 mM in DMSO 105622-85-3
TA-03, 10 mM in DMSO 5778-80-3
TAK-960, 10 mM in DMSO 1137868-52-0
Thalidomide-NH-PEG1-NH2 hydrochloride 2154342-56-8
Acetic acid, 2-[4-[(2-ethyl-3-benzofuranyl)carbonyl]phenoxy]-, 10 mM in DMSO 91627-33-7
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid 816450-73-4
TAK-418, 10 mM in DMSO 1818252-53-7
214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318
Copyright 2007©  ChemicalBook. All rights reserved.